NCT02892123 2024-11-27
Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing Cancers
Jazz Pharmaceuticals
Phase 1 Completed
Jazz Pharmaceuticals
Puma Biotechnology, Inc.
GlaxoSmithKline
Hoffmann-La Roche
Sanofi
Mast Therapeutics, Inc.
Metronome Therapeutics